• 1
    Terzolo M, Bovio S, Reimondo G, Pia A, Osella G, Borretta G, Angeli A. Subclinical Cushing's syndrome in adrenal incidentalomas. Endocrinol Metab Clin North Am. 2005; 34: 42339.
  • 2
    Chiodini I. Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab. 2011; 96: 122336.
  • 3
    Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A. Adrenal incidentaloma: a new cause of the metabolic syndrome?. J Clin Endocrinol Metab. 2002; 87: 9981003.
  • 4
    Chiodini I, Battista C, Carnevale V, Trischitta V, Scillitani A. Skeletal involvement in adults patients with endogenous hypercortisolism. J Endocrinol Invest. 2007; 31: 26776.
  • 5
    Tauchmanovà L, Rossi R, Nuzzo V, Del Puente A, Esposito-Del Puente A, Pizzi C, Fonderico F, Lupoli G, Lombardi G. Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. Eur J Endocrinol. 2001; 145: 2417.
  • 6
    Torlontano M, Chiodini I, Pileri Guglielmi G, Cammisa M, Modoni S, Carnevale V, Trischitta V, Scillitani A. Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab. 1999; 84: 23815.
  • 7
    Chiodini I, Torlontano M, Carnevale V, Guglielmi G, Cammisa M, Trischitta V, Scillitani A. Bone loss rate in adrenal incidentalomas: a longitudinal study. J Clin Endocrinol Metab. 2001; 86: 533741.
  • 8
    Chiodini I, Tauchmanovà L, Torlontano M, Battista C, Guglielmi G, Cammisa M, Colao A, Carnevale V, Rossi R, Di Lembo S, Trischitta V, Scillitani A. Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism. J Clin Endocrinol Metab. 2002; 87: 54914.
  • 9
    Bardet S, Rohmer V, Boux de Casson F, Coffin C, Ronci N, Sabatier JP, Lecomte P, Audran M, Henry-Amar M, Tabarin A. [Bone density and biochemical bone markers in patients with adrenal incidentalomas: effect of subclinical hypercortisolism]. Rev Med Interne. 2002 Jun; 23(6): 50817. French.
  • 10
    Osella G, Reimondo G, Peretti P, Alì A, Paccotti P. The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis. J Clin Endocrinol Metab. 2001; 86: 6047.
  • 11
    Chiodini I, Guglielmi G, Battista C, Carnevale V, Torlontano M, Cammisa M, Trischitta V, Scillitani A. Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effect of subclinical hypercortisolism and gonadal status. J Clin Endocrinol Metab. 2004; 89: 223741.
  • 12
    Chiodini I, Viti R, Coletti F, Guglielmi G, Battista C, Ermetici F, Morelli V, Salcuni A, Carnevale V, Urbano F, Muscarella S, Ambrosi B, Arosio M, Beck-Peccoz P, Scillitani A. Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures. Clin Endocrinol. 2009; 70: 20813.
  • 13
    Chiodini I, Morelli V, Masserini B, Salcuni A, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Iorio L, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A. Factors influencing bone mineral density and quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian Multicenter Study. J Clin Endocrinol Metab. 2009; 94: 320714.
  • 14
    Morelli V, Eller Vainicher C, Stefano Salcuni A, Coletti F, Iorio L, Muscogiuri G, Della Casa S, Arosio M, Ambrosi B, Beck-Peccoz P, Chiodini I. Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study. J Bone Miner Res. 2011; 26: 181621.
  • 15
    Lane NE, Yao W. Glucocorticoid-induced bone fragility: new insights. Ann N Y Acad Sci. 2010; 1192: 813.
  • 16
    Crans GG, Genant HK, Krege JH. Prognostic utility of a semiquantitative spinal deformity index. Bone. 2005; 37: 1759.
  • 17
    Genant HK, Delmas PD, Chen P, Jiang Y, Eriksen EF, Dalsky GP, Marcus R, San Martin J. Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int. 2007; 18: 6976.
  • 18
    Thomsen JS, Ebbesen EL, Mosekilde L. Predicting human vertebral bone strength by vertebral static histomorphometry. Bone. 2002; 30: 5028.
  • 19
    Link TM, Majumdar S, Grampp S, Guglielmi G, van Kuijk C, Imhof H, Glueer CC, Adams JE. Imaging of trabecular bone structure in osteoporosis. Eur Radiol. 1999; 9: 17818.
  • 20
    Bousson V, Bergot C, Sutter B, Levitz P, Cortet B. the Scientific Committee of the GRIO (Groupe de Recherche et d'Information sur les Ostéoporoses). Trabecular bone score (TBS); available knowledge, clinical relevance, and future prospects. Osteoporos Int. 2012 May; 23(5): 1489501.
  • 21
    Pothuaud L, Carceller P, Hans D. Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone. 2008; 42: 77587.
  • 22
    Pothuaud L, Barthe N, Krieg MA, Mehsen N, Carceller P, Hans D. Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case-control study. J Clin Densitom. 2009; 12: 1706.
  • 23
    Hans D, Barthe N, Boutroy S, Pothuaud L, Winzenrieth R, Krieg MA. Correlations between trabecular bone score, measured using anteroposterior dual X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J Clin Densitom. 2011; 14: 30212.
  • 24
    Rabier B, Héraud A, Grand-Lenoir C, Winzenrieth R, Hans D. A multicentre, retrospective case-control study assessing the role of trabecular bone score (TBS) in menopausal Caucasian women with low areal bone mineral density (BMDa): analysing the odds of vertebral fracture. Bone. 2010; 46: 17681.
  • 25
    Winzenrieth R, Dufour R, Pothuaud L, Hans D. A retrospective case-control study assessing the role of trabecular bone score in postmenopausal Caucasian women with osteopenia: analyzing the odds of vertebral fracture. Calcif Tissue Int. 2010; 86: 1049.
  • 26
    Hans D, Goertzen AL, Krieg MA, Leslie WD. Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density; The Manitoba Study. J Bone Miner Res. 2001; 26: 27629.
  • 27
    Hans D, Winzenrieth R, Aubry-Rozier B, Stoll D, Lamy O, Krieg MA. Can the trabecular bone score (TBS) be considered as a major clinical risk factor (CRF) of osteoporotic fractures? A meta-like analysis. World Congress on Debates & Consensus in Bone, Muscles & Joint Diseases. 2012 January 19-22. Barcelona (Spain).
  • 28
    Colson F, Picard A, Rabier B, Piperno M, Vignon E. Trabecular bone microarchitecture alteration in glucocorticoids treated women in clinical routine?: a TBS evaluation [Internet]. ASBMR 31st Annual Meeting. Poster Sessions, Presentation Number: SU0452. J Bone Miner Res. 2009; 24(Suppl 1):[cited 2012 May 4]. Available from:
  • 29
    Brebàn S, Kolta S, Briot K, Paternotte S, Ghazi M, Fechtenbaum J, Dougadous M, Roux C. Combination of bone mineral density and trabecular bone score for vertebral fracture prediction in secondary osteoporosis [Internet]. J Bone Miner Res. 2010; 25(Suppl 1):[cited 2012 May 4]. Available from:
  • 30
    Simonelli C, Adler RA, Blake GM, Caudill JAP, Khan A, Leib E, Maricic M, Prior JC, Eis SR, Rosen C, Kendler DL. Dual-energy x-ray absorptiometry technical issues: the 2007 ISCD official positions. J Clin Densitom. 2008; 1: 10922.
  • 31
    Genant HK, Wu CY, van Knijk C, Nevitt M. Vertebral fracture assessment using a semi-quantitative technique. J Bone Miner Res. 1993; 8: 113748.
  • 32
    Dufour R, Heraud A. Lumbar spine micro-architecture in French women derived from DXA: TBS normative data. International Society for Clinical Densitometry, 15th Annual Meeting. 2009 March 11-14. Orlando, FL, USA. p. 104.
  • 33
    Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab. 2006; 17: 1449.
  • 34
    Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, Santini SA, Guglielmi G, Carnevale V, Scillitani A. Subclinical hypercortisolism among outpatients referred for “osteoporosis”. Ann Intern Med. 2007; 147: 5418.
  • 35
    Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008; 93: 152640.
  • 36
    Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Savoca C, Viti R, Coletti F, Guglielmi G, Battista C, Iorio L, Beck-Peccoz P, Ambrosi B, Arosio M, Scillitani A, Chiodini I. Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clin Endocrinol (Oxf). 2010; 73: 1616.